Hepion Pharmaceuticals, Inc. — Form D

Hepion Pharmaceuticals, Inc. of RED BANK, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-23. The offering totals $12.5M, of which $9.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Timothy BlockDirectorRed Bank, NJ
John BrancaccioDirectorSan Diego, CA
Gary JacobDirectorSan Diego, CA
Christopher McGuiganDirectorEdison, NJ
James SapirsteinDirectorCincinnati, OH
Bill HornungExecutive OfficerEdison, NJ
James SapirsteinExecutive OfficerCincinnati, OH
Sireesh AppajosyulaRelated PersonRed Bank, NJ
Gary StetzRelated PersonRed Bank, NJ
Vincent LoPrioreRelated PersonRed Bank, NJ
Robert FosterDirectorWaverly, OH
Robert FosterExecutive OfficerWaverly, OH
Kaouthar P LbiatiDirectorEdison, NJ
John CavanExecutive OfficerEdison, NJ
Michael P PurcellDirectorEdison, NJ
Timothy P BlockDirectorEdison, NJ
Anand ReddiDirectorEdison, NJ
Petrus P WijngaardDirectorEdison, NJ
Gary S JacobsDirectorEdison, NJ
Arnold P LippaDirectorEdison, NJ
Todd HobbsExecutive OfficerEdison, NJ
Thomas P AdamsDirectorEdison, NJ
John P CavanExecutive OfficerEdison, NJ
John P BrancaccioDirectorNew Hope, PA
Timothy BlockRelated PersonRed Bank, NJ

Other filings by this issuer (8)

FiledFormOfferingSold
2026-08-05D$3.1M$3.1M
2026-04-22D$700K$700K
2024-07-24D$2.9M$2.9M
2023-10-03D$5.0M$5.0M
2022-11-15D$20.0M$20.0M
2019-03-27D$1.3M$1.3M
2014-08-22D$4.7M$4.7M
2014-02-14D$3.2M$3.2M

More